Impact of Immune-Related Adverse Events on Survival in Patients With Gastrointestinal Cancer Treated With Immune Checkpoint Inhibitors: A Meta-Analysis
The presence of irAEs in patients with GI cancer receiving ICIs correlates with significantly better OS and PFS. This suggests that irAEs may be a potential biomarker for predicting treatment response.
Authors
- Lijuan Qin
- Juan Wu (ORCID: https://orcid.org/0000-0002-2580-9936)
- Wenxing Yan (ORCID: https://orcid.org/0000-0002-4541-304X)
- Xueli Jia
- Yingying Han (ORCID: https://orcid.org/0000-0002-9736-6126)
Institutions
- Shanxi Medical University (CN)
Publication Details
- Journal
- Clinical and Translational Gastroenterology
- Published
- 2025-06-17
- DOI
- https://doi.org/10.14309/ctg.0000000000000875
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05